Chia‐Yen Lin

1.2k total citations
63 papers, 920 citations indexed

About

Chia‐Yen Lin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Chia‐Yen Lin has authored 63 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 16 papers in Oncology. Recurrent topics in Chia‐Yen Lin's work include Prostate Cancer Treatment and Research (16 papers), Pancreatitis Pathology and Treatment (12 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Chia‐Yen Lin is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Pancreatitis Pathology and Treatment (12 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Chia‐Yen Lin collaborates with scholars based in Taiwan, China and United States. Chia‐Yen Lin's co-authors include S Songcharoen, S. Nayiager, M. Keiserman, C. Codding, T. Li, Maxime Dougados, Michael Schiff, J-C Becker, Alberto Berman and R. Aranda and has published in prestigious journals such as PLoS ONE, Biomaterials and Scientific Reports.

In The Last Decade

Chia‐Yen Lin

56 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chia‐Yen Lin Taiwan 13 366 172 162 145 142 63 920
Ulf Müeller-Ladner Germany 13 627 1.7× 158 0.9× 203 1.3× 124 0.9× 215 1.5× 28 1.3k
Nobunori Takahashi Japan 18 492 1.3× 116 0.7× 266 1.6× 51 0.4× 206 1.5× 108 996
Monika Prochorec‐Sobieszek Poland 21 221 0.6× 128 0.7× 320 2.0× 171 1.2× 236 1.7× 106 1.2k
Ken Yamaji Japan 19 547 1.5× 120 0.7× 154 1.0× 128 0.9× 510 3.6× 135 1.3k
Yannick Degboé France 20 563 1.5× 214 1.2× 231 1.4× 38 0.3× 342 2.4× 70 1.1k
Satoshi Koizumi Japan 13 192 0.5× 147 0.9× 194 1.2× 113 0.8× 71 0.5× 110 990
Marta J. Petersen United States 20 263 0.7× 55 0.3× 181 1.1× 103 0.7× 61 0.4× 43 1.2k
Mark Pearson United Kingdom 15 432 1.2× 57 0.3× 316 2.0× 130 0.9× 199 1.4× 33 1.0k
Jung Woo Lee South Korea 19 91 0.2× 233 1.4× 216 1.3× 154 1.1× 79 0.6× 94 1.2k
Lindi Jiang China 17 318 0.9× 95 0.6× 144 0.9× 332 2.3× 245 1.7× 78 893

Countries citing papers authored by Chia‐Yen Lin

Since Specialization
Citations

This map shows the geographic impact of Chia‐Yen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Yen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Yen Lin more than expected).

Fields of papers citing papers by Chia‐Yen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Yen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Yen Lin. The network helps show where Chia‐Yen Lin may publish in the future.

Co-authorship network of co-authors of Chia‐Yen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Yen Lin. A scholar is included among the top collaborators of Chia‐Yen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Yen Lin. Chia‐Yen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yung‐Wei, Chia‐Yen Lin, Yu-Ching Wen, et al.. (2025). Genetic variants of IGF2BP2 as potential predictors for perineural invasion of prostate cancer in a Taiwanese population. International Journal of Medical Sciences. 22(6). 1269–1277. 1 indexed citations
2.
Chung, Mu‐Chi, Chia‐Yen Lin, Po‐Jen Hsiao, et al.. (2025). Use of Sodium‐Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi‐Database and Cross‐Country Study in Patients With Type 2 Diabetes Mellitus. Clinical Pharmacology & Therapeutics. 117(6). 1775–1783. 1 indexed citations
3.
4.
Lin, Chia‐Yen, Chunli Wang, Cheng‐Kuang Yang, et al.. (2024). The impact of novel hormonal agents on fracture risk in prostate cancer patients: a nationwide population-based cohort study. Scientific Reports. 14(1). 26696–26696.
5.
Hu, Sung‐Lin, Shan‐Chi Liu, Chia‐Yen Lin, et al.. (2024). Genetic associations of visfatin polymorphisms with clinicopathologic characteristics of prostate cancer in Taiwanese males. International Journal of Medical Sciences. 21(13). 2494–2501. 1 indexed citations
6.
Chen, Chuan-Shu, et al.. (2024). Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients. PLoS ONE. 19(9). e0309941–e0309941. 1 indexed citations
7.
Yang, Cheng‐Kuang, Jian‐Ri Li, Chuan-Shu Chen, et al.. (2024). Comparative analysis of novel hormonal agents in non-metastatic castration-resistant prostate cancer: A Taiwanese perspective. PLoS ONE. 19(8). e0306900–e0306900. 1 indexed citations
8.
Li, Jian‐Ri, Chuan-Shu Chen, Chia‐Yen Lin, et al.. (2024). Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database. PLoS ONE. 19(3). e0299102–e0299102. 1 indexed citations
9.
Yang, Chi‐Rei, Yen‐Chuan Ou, Chen‐Li Cheng, et al.. (2023). Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer. Oncology Letters. 26(1). 284–284. 2 indexed citations
10.
Peng, Jie, Wei Qin, Jiarong Li, et al.. (2023). Escherichia coli infection indicates favorable outcomes in patients with infected pancreatic necrosis. Frontiers in Cellular and Infection Microbiology. 13. 1107326–1107326. 1 indexed citations
11.
12.
Li, Jiarong, et al.. (2022). Early-onset emphysematous pancreatitis indicates poor outcomes in patients with infected pancreatic necrosis. Digestive and Liver Disease. 54(11). 1527–1532. 6 indexed citations
13.
Lin, Chia‐Yen, et al.. (2022). Application of metagenomic next-generation sequencing for suspected infected pancreatic necrosis. Pancreatology. 22(7). 864–870. 4 indexed citations
14.
Chen, Chuan-Shu, Chia‐Yen Lin, Chunli Wang, et al.. (2020). Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage. Urologic Oncology Seminars and Original Investigations. 39(2). 132.e13–132.e26. 3 indexed citations
15.
Lin, Chia‐Yen, Shian‐Shiang Wang, Cheng‐Kuang Yang, et al.. (2019). Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy. Urologic Oncology Seminars and Original Investigations. 37(11). 814.e9–814.e16. 13 indexed citations
16.
Hung, Sheng-Chun, Shian‐Shiang Wang, Jian‐Ri Li, et al.. (2019). Impact of RAGE polymorphisms on urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Urologic Oncology Seminars and Original Investigations. 37(9). 573.e9–573.e17. 9 indexed citations
17.
Hung, Sheng-Chun, Ying‐Erh Chou, Jian‐Ri Li, et al.. (2019). Functional genetic variant of WW domain containing oxidoreductase gene associated with urothelial cell carcinoma clinicopathologic characteristics and long-term survival. Urologic Oncology Seminars and Original Investigations. 38(2). 41.e1–41.e9. 5 indexed citations
18.
19.
Li, Jian‐Ri, Yen‐Chuan Ou, Shian‐Shiang Wang, et al.. (2018). The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma. Anticancer Research. 38(9). 5339–5345. 13 indexed citations
20.
Lin, Chia‐Yen, Chi‐Rei Yang, Chen‐Li Cheng, et al.. (2014). Application in robotic urologic surgery. Journal of the Chinese Medical Association. 77(5). 242–245. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulf Müeller-Ladner Breakdown of academic impact, for papers by Nobunori Takahashi Breakdown of academic impact, for papers by Monika Prochorec‐Sobieszek Breakdown of academic impact, for papers by Ken Yamaji Breakdown of academic impact, for papers by Yannick Degboé Breakdown of academic impact, for papers by Satoshi Koizumi Breakdown of academic impact, for papers by Marta J. Petersen Breakdown of academic impact, for papers by Mark Pearson Breakdown of academic impact, for papers by Jung Woo Lee Breakdown of academic impact, for papers by Lindi Jiang
Rankless by CCL
2026